Stephens & Co. Downgrades BioLife Solutions to Equal-Weight, Lowers Price Target to $31

Benzinga Newsdesk www.benzinga.com Negative 93.2%

Neg 93.2% Neu 0% Pos 0%

Stephens & Co. analyst Helfey Hannah downgrades BioLife Solutions (NASDAQ:BLFS) from Overweight to Equal-Weight and lowers the price target from $32 to $31.